Frustaci, A.M.; Deodato, M.; Zamprogna, G.; Cairoli, R.; Montillo, M.; Tedeschi, A.
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities. Cancers 2023, 15, 1504.
https://doi.org/10.3390/cancers15051504
AMA Style
Frustaci AM, Deodato M, Zamprogna G, Cairoli R, Montillo M, Tedeschi A.
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities. Cancers. 2023; 15(5):1504.
https://doi.org/10.3390/cancers15051504
Chicago/Turabian Style
Frustaci, Anna Maria, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo, and Alessandra Tedeschi.
2023. "Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities" Cancers 15, no. 5: 1504.
https://doi.org/10.3390/cancers15051504
APA Style
Frustaci, A. M., Deodato, M., Zamprogna, G., Cairoli, R., Montillo, M., & Tedeschi, A.
(2023). Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities. Cancers, 15(5), 1504.
https://doi.org/10.3390/cancers15051504